Financials Body and Mind Inc.

Equities

BMMJ

US09689V1008

Pharmaceuticals

Market Closed - OTC Markets 03:53:26 2024-04-26 pm EDT 5-day change 1st Jan Change
0.0794 USD +13.43% Intraday chart for Body and Mind Inc. +4.47% +10.89%

Valuation

Fiscal Period: July 2018 2019 2020 2021 2022 2023
Capitalization 1 14.26 66.89 24.73 38.18 11.37 11.88
Enterprise Value (EV) 1 16.11 57.88 26.01 38.7 23.04 30.26
P/E ratio -6.53 x -12.7 x -5.44 x -16.8 x -0.39 x -0.52 x
Yield - - - - - -
Capitalization / Revenue 5.91 x 14.5 x 4.68 x 1.49 x 0.36 x 0.52 x
EV / Revenue 6.68 x 12.5 x 4.92 x 1.51 x 0.73 x 1.33 x
EV / EBITDA -14.9 x -23.6 x -5.18 x 15.3 x -17.9 x -5.16 x
EV / FCF -10.1 x -27.6 x -8.48 x 10.2 x 16.7 x -15.2 x
FCF Yield -9.91% -3.62% -11.8% 9.84% 6% -6.57%
Price to Book 1.32 x 2.02 x 0.74 x 1.11 x 1.18 x -1.16 x
Nbr of stocks (in thousands) 47,775 97,273 107,514 109,078 113,669 146,637
Reference price 2 0.2985 0.6876 0.2300 0.3500 0.1000 0.0810
Announcement Date 11/13/18 11/13/19 12/15/20 11/18/21 1/17/23 11/14/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: July 2018 2019 2020 2021 2022 2023
Net sales 1 2.413 4.612 5.287 25.7 31.64 22.82
EBITDA 1 -1.081 -2.455 -5.025 2.537 -1.284 -5.868
EBIT 1 -1.151 -2.744 -5.481 0.6487 -3.52 -7.67
Operating Margin -47.69% -59.5% -103.66% 2.52% -11.12% -33.61%
Earnings before Tax (EBT) 1 -2.686 -3.753 -4.464 0.1902 -25.63 -18.15
Net income 1 -1.781 -3.753 -4.341 -2.261 -28.68 -20.78
Net margin -73.81% -81.37% -82.09% -8.8% -90.64% -91.07%
EPS 2 -0.0457 -0.0540 -0.0423 -0.0208 -0.2556 -0.1547
Free Cash Flow 1 -1.596 -2.097 -3.066 3.81 1.383 -1.99
FCF margin -66.14% -45.46% -57.99% 14.82% 4.37% -8.72%
FCF Conversion (EBITDA) - - - 150.17% - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 11/13/18 11/13/19 12/15/20 11/18/21 1/17/23 11/14/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: July 2018 2019 2020 2021 2022 2023
Net Debt 1 1.85 - 1.28 0.53 11.7 18.4
Net Cash position 1 - 9 - - - -
Leverage (Debt/EBITDA) -1.712 x - -0.2554 x 0.2075 x -9.093 x -3.133 x
Free Cash Flow 1 -1.6 -2.1 -3.07 3.81 1.38 -1.99
ROE (net income / shareholders' equity) -32.1% -17.1% -13.8% -5.84% -127% -5,308%
ROA (Net income/ Total Assets) -8.98% -6.63% -9.13% 0.93% -5.56% -18.4%
Assets 1 19.84 56.61 47.54 -242.4 515.9 113.2
Book Value Per Share 2 0.2300 0.3400 0.3100 0.3100 0.0800 -0.0700
Cash Flow per Share 2 0.0100 0.0900 0.0100 0.0700 0.0200 0.0100
Capex 1 0.56 0.37 0.87 0.4 0.83 0.99
Capex / Sales 23.39% 7.98% 16.49% 1.57% 2.62% 4.35%
Announcement Date 11/13/18 11/13/19 12/15/20 11/18/21 1/17/23 11/14/23
1USD in Million2USD
Estimates
  1. Stock Market
  2. Equities
  3. BMMJ Stock
  4. Financials Body and Mind Inc.